side effects of microdosing glp-1 medications are changing how people think about weight loss, diabetes care and even cravings. Now, more people are talking about “microdosing” GLP-1s. That usually means taking less than the typical prescribed Foundayo (Orforglipron) for Weight Loss:

Once food passes through the gastrointestinal tract (GI), taste receptors, along with mechanosensors and chemoreceptors within the GI tract, transmit information via afferent branches of the vagus nerve and hormonal signaling (e.g., GLP-1, GIP, PYY, insulin, among others) (114, 115)

However, excessive fat intake may delay gastric emptying beyond therapeutic benefit

Due to potential risks of medullary thyroid carcinoma and multiple endocrine neoplasia, its not recommended for individuals with a personal or family history of these conditions [45]

Flow Wellness provides ongoing support for patients using GLP-1 medications

Age-associated cholesterol reduction triggers brain insulin resistance by facilitating ligand-independent receptor activation and pathway desensitization

A BMI of 27 or higher plus a weight-related health issue like type 2 diabetes or high blood pressure